FBT
First Trust NYSE Arca Biotechnology Index Fund
Set alert
278.55 USD -1.75 -0.62%
277.59 Day range 283.21
188.61 52-week range 280.30
- YTD
- +34.88%
- 1 year
- +47.69%
- Open
- 280.92
- Prev close
- 280.30
- Mkt cap
- 1.74B
- Vol
- 86.61K
- Avg vol
- 61.18K
- EPS
- 9.19
- P/E
- 30.32
- Div yield
- 0.00%
More statistics
- Low
- 277.59
- High
- 283.21
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 268.86
- 200-d avg
- 232.65
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 30.34
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 268.86
- 200-day average
- 232.65
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
News
- ETFs That You May Consider Amid a Strengthening Biotech Outlook
- Which Healthcare ETF Is the Better Buy: Simplify's Mission-Driven PINK or First Trust's Biotech FBT?
- Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT?
- Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?
- Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
- Why Is Natera Stock Gaining Tuesday?
- Moderna's Legal Hit Steals Spotlight From Strong Sales
- FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars
- Moderna, Mexico Partner To Boost Local Vaccine Production
- Moderna (MRNA) Stock Pulls Back After Recent Strength
Your note
Sign in to keep a note on FBT — it syncs with the Stock Master app.